Education
About Us
Working with TipRanks
Follow Us
LivaNova PLC (LIVN)
NASDAQ:LIVN
Earnings Data
Report Date
May 06, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.9Last Year’s EPS
0.88Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call communicated solid commercial and financial momentum: double-digit growth in core businesses, margin expansion, stronger cash and materially lower debt, meaningful Medicare reimbursement improvements for epilepsy, and multiple clinical/regulatory milestones (FDA digital platform approval, OSPREY data, OSA PMA timeline). Offsetting items include supply constraints for oxygenators, increased R&D and capex for strategic launches, a significant assumed SNIA cash payment in 2026, and conservative near-term guidance reflecting component constraints and tougher comps. Overall, the company appears well-positioned for medium-term growth while prudently managing near-term operational and cash assumptions.Company Guidance
Top-line Growth and Segment Performance
Q4 revenue of $361M, up 9.5% on a constant currency and organic basis; full-year cardiopulmonary revenue $785M, +13% YoY; cardiopulmonary Q4 revenue $207M, +10% YoY; epilepsy full-year revenue growth 6% and Q4 epilepsy +9% YoY with broad regional strength (Europe & RoW +17% Q4; U.S. epilepsy +8% Q4).
Adjusted Profitability Expansion
Adjusted operating income rose to $64M in Q4 from $56M a year ago; adjusted operating margin improved to 18% from 17%; adjusted diluted EPS $0.86 vs $0.81 in Q4 2024.
Strong Cash Position and Debt Reduction
Cash balance of $636M at year-end vs $429M prior year; total debt reduced to $377M from $628M year-end 2024 (including early repayments and convertible note repayment).
Free Cash Flow and Guidance
Full-year 2025 adjusted free cash flow $183M vs $163M prior year; 2026 guidance: revenue growth of 6%–7% (constant currency), adjusted diluted EPS $4.15–$4.25 (~8% growth at midpoint), adjusted FCF guide $160M–$180M (includes assumptions noted).
Epilepsy Reimbursement and Clinical Momentum
Medicare provider reimbursement for VNS Therapy increased ~48% for new patient implants and ~47% for end-of-service procedures effective 1/1/2026; CORE VNS (800 patients) delivered compelling, durable results reshaping clinical perception and supporting expanded access.
Regulatory and Innovation Progress
FDA approval received for cloud-based digital health platform (foundation for Connected Care); OSPREY 12-month OSA dataset imminent; modular PMA on track with expectation of clinical trial device PMA in H1 and MRI-compatible supplement to follow.
Product Adoption and Commercial Levers
Essence represented ~55% of annual HLM placements in 2025 with a target of ~80% by 2026; cardiopulmonary consumables grew mid-teens in Q4 and low-teens for the full year driven by market share gains, procedure growth and pricing.
Strategic Investments and Future Launches
Design freeze completed for next-gen oxygenator (moving to scale-up); planned launch timeline for next-gen oxygenator ~2028; limited market rollout of clinician portal in 2026 and full digital/BT-enabled epilepsy generator launch planned for 2027.
LIVN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LIVN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 25, 2026 | $69.05 | $70.29 | +1.80% |
Nov 05, 2025 | $53.94 | $50.81 | -5.80% |
Aug 06, 2025 | $42.61 | $47.36 | +11.15% |
May 07, 2025 | $35.16 | $43.50 | +23.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does LivaNova PLC (LIVN) report earnings?
LivaNova PLC (LIVN) is schdueled to report earning on May 06, 2026, Before Open (Confirmed).
What is LivaNova PLC (LIVN) earnings time?
LivaNova PLC (LIVN) earnings time is at May 06, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LIVN EPS forecast?
LIVN EPS forecast for the fiscal quarter 2026 (Q1) is 0.9.